206 related articles for article (PubMed ID: 9643634)
1. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report.
Claahsen HL; Semmekrot BA; van Dongen PW; Mattijssen V
Am J Perinatol; 1998 May; 15(5):295-7. PubMed ID: 9643634
[TBL] [Abstract][Full Text] [Related]
2. Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester.
Reynoso EE; Huerta F
Acta Oncol; 1994; 33(6):709-10. PubMed ID: 7946455
[No Abstract] [Full Text] [Related]
3. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy.
Niedermeier DM; Frei-Lahr DA; Hall PD
Pharmacotherapy; 2005 Aug; 25(8):1134-40. PubMed ID: 16207105
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Burkitt's lymphoma during pregnancy.
Lam MS
Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
[TBL] [Abstract][Full Text] [Related]
5. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
6. Idarubicin administered during pregnancy: its effects on the fetus.
Matsuo K; Shimoya K; Ueda S; Wada K; Koyama M; Murata Y
Gynecol Obstet Invest; 2004; 58(4):186-8. PubMed ID: 15256824
[TBL] [Abstract][Full Text] [Related]
7. [Acute myelogenous leukemia developed at the 26th week of gestation].
Tashiro H; Umezawa K; Shirota M; Oka Y; Shirasaki R; Nishi R; Taguchi A; Akiyama N; Kawasugi K; Ayabe T; Shirafuji N
Rinsho Ketsueki; 2011 Jan; 52(1):18-22. PubMed ID: 21378477
[TBL] [Abstract][Full Text] [Related]
8. Transient neonatal myelosuppression after fetal exposure to maternal chemotherapy. Case report and review of the literature.
Udink ten Cate FE; ten Hove CH; Nix WM; de Vries JI; van de Loosdrecht AA; van Elburg RM
Neonatology; 2009; 95(1):80-5. PubMed ID: 18787341
[TBL] [Abstract][Full Text] [Related]
9. Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside.
Hogan WJ; Letendre L; Litzow MR; Tefferi A; Hoagland HC; Pruthi RK; Kaufmann SH
Mayo Clin Proc; 2002 Aug; 77(8):760-2. PubMed ID: 12173711
[TBL] [Abstract][Full Text] [Related]
10. Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML.
Baumgärtner AK; Oberhoffer R; Jacobs VR; Ostermayer E; Menzel H; Voigt M; Schneider KT; Pildner von Steinburg S
Onkologie; 2009 Feb; 32(1-2):40-3. PubMed ID: 19209018
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute myeloid leukemia during pregnancy.
Chang A; Patel S
Ann Pharmacother; 2015 Jan; 49(1):48-68. PubMed ID: 25258419
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
13. Acute promyelocytic leukemia during pregnancy.
Ganzitti L; Fachechi G; Driul L; Marchesoni D
Fertil Steril; 2010 Nov; 94(6):2330.e5-6. PubMed ID: 20447623
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy exposure to midostaurin in the first trimester.
Ojha S; Ooi MG
Ann Hematol; 2020 Feb; 99(2):355-356. PubMed ID: 31897677
[No Abstract] [Full Text] [Related]
15. Children exposed to chemotherapy in utero.
Gwyn K
J Natl Cancer Inst Monogr; 2005; (34):69-71. PubMed ID: 15784828
[TBL] [Abstract][Full Text] [Related]
16. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
[No Abstract] [Full Text] [Related]
17. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
Vogler WR; Velez-Garcia E; Omura G; Raney M
Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
[No Abstract] [Full Text] [Related]
18. How I treat acute and chronic leukemia in pregnancy.
Shapira T; Pereg D; Lishner M
Blood Rev; 2008 Sep; 22(5):247-59. PubMed ID: 18472198
[TBL] [Abstract][Full Text] [Related]
19. Fetal outcome after in utero exposure to cancer chemotherapy.
Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloblastic leukemia in pregnancy: a case report and review of the literature.
Yucebilgin MS; Cagirgan S; Donmez A; Ozkinay E; Akercan F; Mgoyi L; Vural F
Eur J Gynaecol Oncol; 2004; 25(1):126-8. PubMed ID: 15053082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
